Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 2, 2005, Pages 322-326

  Nicolaides, Kypros H ^a   Chervenak, Frank A ^b   McCullough, Laurence B ^c   Avgidou, Kyriaki ^a   Papageorghiou, Aris ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Decision making; Ethics; Nuchal translucency; Risk assessment; Screening; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME ABERRATION; DECISION MAKING; DIAGNOSTIC PROCEDURE; EMPIRICISM; ETHICS; EVIDENCE BASED MEDICINE; FEMALE; FETUS; FETUS ECHOGRAPHY; HUMAN; MATERNAL AGE; MATERNAL SERUM; MEDICAL ASSESSMENT; OBSTETRICS; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SPONTANEOUS ABORTION; TRISOMY 21;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DECISION MAKING; DOWN SYNDROME; ETHICS, CLINICAL; FEMALE; HUMANS; INFORMED CONSENT; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RISK ASSESSMENT;

EID: 23644445294     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.02.134     Document Type: Article

References (17)

1. A.D. Oxman, D.J. Cook, and G.H. Guyatt Users' guide to the medical literature. VI. How to use an overview JAMA 272 1994 1367 1371
2. G.H. Guyatt, D.L. Sackett, and D.J. Cook Users' guide to the medical literature. II. How to use an overview JAMA 270 1993 2598 2601
3. G.H. Guyatt, D.L. Sackett, and D.J. Cook Users' guide to the medical literature. II. How to use an article about therapy or prevention: B, What were the results and will they help me in caring for my patients? JAMA 271 1994 59 63
4. M.C. Wilson, R.S. Hayward, S.R. Tunis, and E.B. Bass Users' guides to the medical literature. VIII. How to use clinical practice guidelines: A, Are the recommendations valid? JAMA 274 1995 570 574
5. M.C. Wilson, R.S. Hayward, S.R. Tunis, and E.B. Bass Users' guides to the medical literature. VIII. How to use clinical practice guidelines: B, What are the recommendations and will they help you in caring for your patients? JAMA 274 1995 1630 1632
6. A. Tabor, J. Philip, M. Madsen, J. Bang, E.B. Obel, and B. Norgaard-Pedersen Randomised controlled trial of genetic amniocentesis in 4,606 low-risk women Lancet i 1986 1287 1293
7. S. Smidt-Jensen, M. Permin, J. Philip, C. Lundsteen, J.M. Zachary, and S.E. Fowler Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling Lancet 340 1992 1238 1244
8. K. Avgidou, A. Papageorghiou, R. Bindra, K. Spencer, and K.H. Nicolaides Prospective screening for trisomy 21 in 30,564 pregnancies in an one stop clinic at 11-13+6 weeks Am J Obstet Gynecol 192 2005 1761 1767
9. K. Spencer, V. Souter, N. Tul, R. Snijders, and K.H. Nicolaides A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy associated plasma protein-A Ultrasound Obstet Gynecol 13 1999 231 237
10. R. Bindra, V. Heath, A. Liao, K. Spencer, and K.H. Nicolaides One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies Ultrasound Obstet Gynecol 20 2002 219 225
11. K. Spencer, C.E. Spencer, M. Power, C. Dawson, and K.H. Nicolaides Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years prospective experience BJOG 110 2003 281 286
12. K.H. Nicolaides, K. Spencer, K. Avgidou, S. Faiola, and O. Falcon Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening Ultrasound Obstet Gynecol 25 2005 221 226
13. N.J. Wald, A. Kennard, A. Hackshaw, and A. McGuire Antenatal screening for Down's syndrome Health Technol Assess 2 1998 1 112
14. K.H. Nicolaides Screening for fetal chromosomal abnormalities: need to change the rules Ultrasound Obstet Gynecol 4 1994 353 354
15. L.B. McCullough, and F.A. Chervenak Ethics in obstetrics and gynecology 1994 Oxford University Press Oxford, UK
16. Chasen ST, McCullough LB, Chervenak FA. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population? Am J Obstet Gynecol 2004;190:769-74.
17. S.T. Chasen, D.W. Skupski, L.B. McCullough, and F.A. Chervenak Prenatal informed consent for sonogram: the time for first-trimester nuchal translucency has come J Ultrasound Med 20 2001 1147 1152